Evidence map›Paper›PMID 31621953›Full record

ArticleThe International journal of health planning and management2020

Patient costs of diabetes mellitus care in public health care facilities in Kenya.

Robinson Oyando, Martin Njoroge, Peter Nguhiu, Antipa Sigilai, Fredrick Kirui, Jane Mbui, Zipporah Bukania, Andrew Obala, Kenneth Munge, Anthony Etyang and 1 more

Abstract read
In one paragraph

Article in The International journal of health planning and management, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Scooping Review of Diabetes Research in Kenya from 2000 to 2020.The East African health research journal · 2024
    Review
  13. Are outpatient costs for hypertension and diabetes care affordable? Evidence from Western Kenya.African journal of primary health care & family medicine · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Robinson OyandoHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID https://orcid.org/0000-0001-8768-6014
Martin NjorogeHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Peter NguhiuHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Antipa SigilaiCentre for Geographic Medicine Research, Kenya Medical Research Institute, KiIifi, Kenya.
Fredrick KiruiCentre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Jane MbuiCentre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Zipporah BukaniaCentre for Public Health Research, Kenya Medical Research Institute, Nairobi, Kenya.
Andrew ObalaMedical Microbiology, Moi University, Eldoret, Kenya.
Kenneth MungeHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Anthony EtyangHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Edwine BarasaHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Funding

KEMRI Internal Research Grant KEMRI IRG-04Wellcome TrustWellcome Trust 092654Wellcome Trust 107527Wellcome Trust 214622
6 · The paper itself

Abstract

objectiveTo estimate the direct and indirect costs of diabetes mellitus care at five public health facilities in Kenya.

methodsWe conducted a cross-sectional study in two counties where diabetes patients aged 18 years and above were interviewed. Data on care-seeking costs were obtained from 163 patients seeking diabetes care at five public facilities using the cost-of-illness approach. Medicines and user charges were classified as direct health care costs while expenses on transport, food, and accommodation were classified as direct non-health care costs. Productivity losses due to diabetes were classified as indirect costs. We computed annual direct and indirect costs borne by these patients.

resultsMore than half (57.7%) of sampled patients had hypertension comorbidity. Overall, the mean annual direct patient cost was KES 53 907 (95% CI, 43 625.4-64 188.6) (US$ 528.5 [95% CI, 427.7-629.3]). Medicines accounted for 52.4%, transport 22.6%, user charges 17.5%, and food 7.5% of total direct costs. Overall mean annual indirect cost was KES 23 174 (95% CI, 20 910-25 438.8) (US$ 227.2 [95% CI, 205-249.4]). Patients reporting hypertension comorbidity incurred higher costs compared with diabetes-only patients. The incidence of catastrophic costs was 63.1% (95% CI, 55.7-70.7) and increased to 75.4% (95% CI, 68.3-82.1) when transport costs were included.

conclusionThere are substantial direct and indirect costs borne by diabetic patients in seeking care from public facilities in Kenya. High incidence of catastrophic costs suggests diabetes services are unaffordable to majority of diabetic patients and illustrate the urgent need to improve financial risk protection to ensure access to care.

Indexed as

Diabetes MellitusFemaleHealth ExpendituresHealth Services AccessibilityHospitals, PublicHumansHypoglycemic AgentsIncomeKenyaMaleMiddle AgedHypoglycemic Agentscatastrophediabetes mellitusKenyaout-of-pocket costsproductivity losses

Identifiers

PMID31621953
PMCPMC7043382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.